Showing 1-5 of 5 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Defining metabolic dysfunction and use of adjunct therapies in type 1 diabetes, using real-world data | Imperial College London | Shivani Misra | Improving Lives | 01-October-2025 to 30-September-2027 | $701,005.42 |
| Harmonizing biomarkers in clinical trials of ustekinumab | King's College London | Timothy Tree | Cures | 01-July-2018 to 31-December-2025 | $727,837.00 |
| Investigating and Optimising the translational potential of NAMPT inhibition in type 1 diabetes | King's College London | Paul Caton | Cures | 01-November-2025 to 31-October-2028 | $859,147.00 |
| Developing The Translational Potential Of The NPY Y4 Receptor For Treating Type 1 Diabetes | King's College London | Gavin Bewick | Cures | 01-June-2022 to 30-November-2026 | $960,119.92 |
| Targeting the islet resident immune population to prevent T1D | King's College London | Gavin Bewick | Cures | 01-October-2024 to 30-September-2027 | $899,758.00 |